A 3-month open-label trial investigated the weight loss and glycemic control effects of benaglutide in patients with T2DM
It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes
Dave Moore said in a press release, At Novo Nordisk, we are committed to developing innovative medicines and will continue to prioritize making them accessible to and affordable for the communities we serve
It effectively suppresses the proliferation and migration of thyroid and liver cancer cells via inhibition of the PI3K/Akt/mTOR signaling pathway [59]
Compounded medications have not undergone FDA review and may differ in safety, efficacy, quality, and purity from FDA-approved drugs
Lund ML, Egerod KL, Engelstoft MS, et al